Not applicableEnded earlyNCT01134315
What this trial is testing
Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice
Who this might be right for
Secondary HyperparathyroidismEnd-Stage Renal Disease
AbbVie (prior sponsor, Abbott) 61